US6822267B1
(en)
*
|
1997-08-20 |
2004-11-23 |
Advantest Corporation |
Signal transmission circuit, CMOS semiconductor device, and circuit board
|
EP1129175A2
(de)
*
|
1998-10-16 |
2001-09-05 |
Novartis AG |
Förderung der selbsterneuerungsaktivität und verbesserte gentransduktion in hematopoietischen stammzellen durch inhibierung des histon-deacetylases
|
DK1140969T3
(da)
*
|
1998-12-14 |
2007-09-17 |
Univ Miami |
Bindevævsvækstfaktorfragmenter og fremgangsmåder og anvendelser deraf
|
US6518012B1
(en)
|
1999-04-02 |
2003-02-11 |
Health Research, Inc. |
Method for regulating the expression of MHC antigens and CD40 by inhibitors of histone deacetylation
|
US6449625B1
(en)
*
|
1999-04-20 |
2002-09-10 |
Lucent Technologies Inc. |
Use of a two-way stack approach to optimize flash memory management for embedded database systems
|
RS50086B
(sr)
*
|
1999-04-22 |
2009-01-22 |
Biogen Idec Ma Inc., |
Upotreba antagonista subjedinica alfa-4 integrina za pripremanje farmaceutskog preparata za tretiranje fibroze
|
CA2369560C
(en)
|
1999-04-27 |
2011-02-01 |
Makoto Nakamuta |
Agent for prophylaxis and treatment of liver disease
|
EP1233958B1
(de)
|
1999-11-23 |
2011-06-29 |
MethylGene Inc. |
Inhibitoren für histone-deacetylase
|
US6544957B2
(en)
|
2000-01-04 |
2003-04-08 |
The Johns Hopkins University |
Methods and reagents for facilitating transcription
|
US7078045B2
(en)
*
|
2000-03-02 |
2006-07-18 |
Sang-Geon Kim |
Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis
|
WO2001076604A1
(en)
*
|
2000-04-07 |
2001-10-18 |
Sang Geon Kim |
Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
|
KR20030067935A
(ko)
*
|
2002-02-09 |
2003-08-19 |
김상건 |
올티프라즈를 포함하는 간경화(간경변증) 치료를 위한 간 조직 재생용 제약 조성물
|
US7256042B2
(en)
|
2000-04-27 |
2007-08-14 |
Geron Corporation |
Process for making hepatocytes from pluripotent stem cells
|
US7282366B2
(en)
|
2000-04-27 |
2007-10-16 |
Geron Corporation |
Hepatocytes for therapy and drug screening made from embryonic stem cells
|
US7473555B2
(en)
|
2000-04-27 |
2009-01-06 |
Geron Corporation |
Protocols for making hepatocytes from embryonic stem cells
|
US6458589B1
(en)
|
2000-04-27 |
2002-10-01 |
Geron Corporation |
Hepatocyte lineage cells derived from pluripotent stem cells
|
CA2423868C
(en)
|
2000-09-29 |
2011-06-07 |
Prolifix Limited |
Carbamic acid compounds comprising an amide linkage as hdac inhibitors
|
AU9013101A
(en)
|
2000-09-29 |
2002-04-22 |
Prolifix Ltd |
Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors
|
GB0023983D0
(en)
|
2000-09-29 |
2000-11-15 |
Prolifix Ltd |
Therapeutic compounds
|
AU2002243231A1
(en)
*
|
2000-11-21 |
2002-07-24 |
Wake Forest University |
Method of treating autoimmune diseases
|
DE60113645T2
(de)
*
|
2001-04-10 |
2006-07-06 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Verwendung von Histonedeacetylasehemmern zur Behandlung von Papillomaviren assoziierte Krankheiten
|
WO2002098405A1
(fr)
*
|
2001-06-05 |
2002-12-12 |
Ajinomoto Co., Inc. |
Inhibiteurs de fibrose du foie
|
AU2002348474A1
(en)
|
2001-10-18 |
2003-04-28 |
The Salk Institute For Biological Studies |
Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
|
AU2002351413A1
(en)
*
|
2001-12-21 |
2003-07-30 |
Patrick Bruggeman |
Method of obtaining purified enterochromaffin cells and methods of using same
|
AU2003219803B8
(en)
*
|
2002-02-15 |
2005-08-25 |
Sloan-Kettering Institute For Cancer Research |
Method of treating TRX mediated diseases
|
AU2005227400B2
(en)
*
|
2002-02-15 |
2008-04-03 |
Sloan-Kettering Institute For Cancer Research |
Method of Treating TRX Mediated Diseases
|
US7501417B2
(en)
|
2002-03-13 |
2009-03-10 |
Janssen Pharmaceutica, N.V. |
Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
|
DK1485348T3
(da)
|
2002-03-13 |
2008-09-29 |
Janssen Pharmaceutica Nv |
Carbonylamino-derivater som nye inhibitorer af histandeacetylase
|
PL214279B1
(pl)
|
2002-03-13 |
2013-07-31 |
Janssen Pharmaceutica Nv |
Pochodna sulfonyloaminowa, sposób jej wytwarzania i zastosowanie oraz kompozycja farmaceutyczna i sposób jej wytwarzania
|
DE60320957D1
(en)
|
2002-03-13 |
2008-06-26 |
Janssen Pharmaceutica Nv |
Sulfonylderivate als histone-deacetylase-inhibitoren
|
AU2003218735B2
(en)
|
2002-03-13 |
2009-03-12 |
Janssen Pharmaceutica N.V. |
Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
|
CA2479906C
(en)
|
2002-04-03 |
2011-02-08 |
Topotarget Uk Limited |
Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
|
US6809118B2
(en)
*
|
2002-07-25 |
2004-10-26 |
Yih-Lin Chung |
Methods for therapy of radiation cutaneous syndrome
|
US8846039B2
(en)
*
|
2002-04-26 |
2014-09-30 |
Asan Laboratories Company (Cayman), Limited |
Method for ameliorating pruritus
|
US8946295B2
(en)
*
|
2002-07-25 |
2015-02-03 |
Sunny Pharmtech Inc. |
Histone hyperacetylating agents for promoting wound healing and preventing scar formation
|
US8883148B2
(en)
*
|
2002-04-26 |
2014-11-11 |
Asan Laboratories Company (Cayman), Limited |
Prevention of joint destruction
|
US20060275370A1
(en)
*
|
2002-07-25 |
2006-12-07 |
Yih-Lin Chung |
Method and compositions for treatment of epithelial damage
|
US8163764B2
(en)
*
|
2002-04-26 |
2012-04-24 |
Asan Laboratories Company (Cayman) Limited |
Skincare methods
|
JP4804004B2
(ja)
*
|
2002-08-20 |
2011-10-26 |
アステラス製薬株式会社 |
関節軟骨細胞外マトリクス分解阻害剤
|
US7154002B1
(en)
|
2002-10-08 |
2006-12-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
JP4612621B2
(ja)
|
2003-01-17 |
2011-01-12 |
トポターゲット ユーケー リミテッド |
Hdac阻害剤としてのエステル又はケトン結合を含むカルバミン酸化合物
|
JP4790594B2
(ja)
|
2003-02-25 |
2011-10-12 |
トポターゲット ユーケー リミテッド |
Hdacインヒビターとしての、二環式ヘテロアリール基を含むヒドロキサム酸化合物
|
JP2006520796A
(ja)
|
2003-03-17 |
2006-09-14 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼインヒビター
|
US20050058611A1
(en)
*
|
2003-08-22 |
2005-03-17 |
L'oreal |
Preventing and/or combating collagen fiber degradation induced under conditions of natural exposure to sunlight
|
WO2005059167A1
(en)
*
|
2003-12-18 |
2005-06-30 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Method for identifying histone deacetylase inhibitors
|
US20050197336A1
(en)
*
|
2004-03-08 |
2005-09-08 |
Miikana Therapeutics Corporation |
Inhibitors of histone deacetylase
|
ATE400261T1
(de)
*
|
2004-03-11 |
2008-07-15 |
Asan Lab Company Cayman Ltd |
Verwendung von histone deacetylase hemmern zur steigerung der therapeutischen wirkung in der radiotherapie und chemotherapie
|
US20080227868A1
(en)
*
|
2004-03-26 |
2008-09-18 |
Volker Schehlmann |
Composition Comprising an Hdac Inhibitor in Combination with a Retinoid
|
US7345043B2
(en)
|
2004-04-01 |
2008-03-18 |
Miikana Therapeutics |
Inhibitors of histone deacetylase
|
ME01058B
(me)
|
2004-07-28 |
2012-10-20 |
Janssen Pharmaceutica Nv |
Supstituisani derivati propenil piperazina kao novi inhibitori histonske deacetilaze
|
KR101261305B1
(ko)
|
2004-07-28 |
2013-05-08 |
얀센 파마슈티카 엔.브이. |
히스톤 디아세틸라제의 신규한 저해제로의 치환된 인돌릴알킬 아미노 유도체
|
EP1824831A2
(de)
|
2004-12-16 |
2007-08-29 |
Takeda San Diego, Inc. |
Histondeacetylase-inhibitoren
|
US20090036435A1
(en)
|
2005-01-21 |
2009-02-05 |
Astex Therapeutics Limited |
Pharmaceutical Compounds
|
AU2006210746B2
(en)
|
2005-02-03 |
2012-04-26 |
Topotarget Uk Limited |
Combination therapies using HDAC inhibitors
|
WO2006088949A1
(en)
|
2005-02-14 |
2006-08-24 |
Miikana Therapeutics, Inc. |
Fused heterocyclic compounds useful as inhibitors of histone deacetylase
|
US20100087328A1
(en)
*
|
2005-03-01 |
2010-04-08 |
The Regents Of The University Of Michigan |
Brm expression and related diagnostics
|
WO2006094068A2
(en)
*
|
2005-03-01 |
2006-09-08 |
The Regents Of The University Of Michigan |
Hdac inhibitors that promote brm expression and brm related diagnostics
|
JP2008540574A
(ja)
|
2005-05-11 |
2008-11-20 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
UA99810C2
(ru)
|
2005-05-13 |
2012-10-10 |
Топотаргет Юк Лимитед |
Фармацевтические составы, которые содержат ингибиторы деацетилазы гистонов
|
DK1885710T3
(en)
|
2005-05-18 |
2015-11-23 |
Janssen Pharmaceutica Nv |
SUBSTITUTED AMINOPROPENYLPIPERIDINE OR MORPHOLINE DERIVATIVES AS UNKNOWN INHIBITORS OF HISTONDEACETYLASE
|
BRPI0613429A2
(pt)
|
2005-07-14 |
2009-02-10 |
Takeda San Diego Inc |
inibidores de histona desacetilase
|
AU2006307918B2
(en)
|
2005-10-27 |
2012-06-21 |
Janssen Pharmaceutica N.V. |
Squaric acid derivatives as inhibitors of histone deacetylase
|
CA2627923C
(en)
|
2005-11-10 |
2016-01-12 |
Topotarget Uk Limited |
Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer
|
AU2007206950B2
(en)
|
2006-01-19 |
2012-02-02 |
Janssen Pharmaceutica N.V. |
Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
|
JP5137848B2
(ja)
|
2006-01-19 |
2013-02-06 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ヒストンデアセチラーゼのインヒビターとしてのピリジン及びピリミジン誘導体
|
CN101370791B
(zh)
|
2006-01-19 |
2012-05-02 |
詹森药业有限公司 |
作为组蛋白脱乙酰基酶抑制剂的吡啶和嘧啶衍生物
|
ES2376121T3
(es)
|
2006-01-19 |
2012-03-09 |
Janssen Pharmaceutica, N.V. |
Derivados de heterociclilalquilo como nuevos inhibidores de histona deacetilasa.
|
JP5225104B2
(ja)
|
2006-01-19 |
2013-07-03 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
新しい、ヒストンデアセチラーゼのインヒビターとしてのアミノフェニル誘導体
|
AU2007206942B2
(en)
|
2006-01-19 |
2012-08-23 |
Janssen Pharmaceutica N.V. |
Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
|
GB2453074B
(en)
|
2006-06-02 |
2011-06-22 |
Geron Corp |
Differentiation of primate pluripotent cells to hepatocyte-lineage cells
|
EP2073807A1
(de)
|
2006-10-12 |
2009-07-01 |
Astex Therapeutics Limited |
Pharmazeutische kombinationen
|
US8916552B2
(en)
|
2006-10-12 |
2014-12-23 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
CN101868446A
(zh)
|
2007-09-25 |
2010-10-20 |
托波塔吉特英国有限公司 |
某些异羟肟酸化合物的合成方法
|
ES2395347T3
(es)
|
2008-03-27 |
2013-02-12 |
Janssen Pharmaceutica, N.V. |
Derivados de indolilalquilamino sustituidos con aza-biciclohexilo como inhibidores novedosos de histona desacetilasa
|
MD4458C1
(ro)
*
|
2014-06-19 |
2017-08-31 |
Мария ДАНУ |
Utilizarea preparatului Polibiolină în tratamentul bolnavilor cu ciroză hepatică
|
TWI808055B
(zh)
|
2016-05-11 |
2023-07-11 |
美商滬亞生物國際有限公司 |
Hdac 抑制劑與 pd-1 抑制劑之組合治療
|
TWI794171B
(zh)
|
2016-05-11 |
2023-03-01 |
美商滬亞生物國際有限公司 |
Hdac抑制劑與pd-l1抑制劑之組合治療
|